M K Proteins Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.M K Proteins Limited IPO Overview

The initial public offering (IPO) of M K Proteins Limited is a public issue under the SME board. The subscription window is scheduled to open on Mar 31, 2017 and close on Apr 7, 2017, with the price band fixed at ₹70 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Mar 31, 2017
• Bidding closes: Apr 7, 2017
• Allotment date: TBA
• Listing date: 2023-06-13
• Minimum investment: TBA

4.M K Proteins Limited IPO GMP Today

No grey market premium has been recorded for M K Proteins Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for M K Proteins Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "M K Proteins Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the —-share lot, at a price within the ₹70 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2023-06-13 on BSE and NSE. Once finalised, check your status on the M K Proteins Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the M K Proteins Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

M K Proteins Limited opens on Mar 31, 2017 and closes on Apr 7, 2017 at ₹70 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.